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ABSTRACT
The Gene Ontology (GO) Consortium (http://www
.geneontology.org) (GOC) continues to develop,
maintain and use a set of structured, controlled
vocabularies for the annotation of genes, gene
products and sequences. The GO ontologies
are expanding both in content and in structure.
Several new relationship types have been intro-
duced and used, along with existing relationships,
to create links between and within the GO domains.
These improve the representation of biology,
facilitate querying, and allow GO developers to sys-
tematically check for and correct inconsistencies
within the GO. Gene product annotation using GO
continues to increase both in the number of total
annotations and in species coverage. GO tools,
such as OBO-Edit, an ontology-editing tool, and
AmiGO, the GOC ontology browser, have seen
major improvements in functionality, speed and
ease of use.
INTRODUCTION
The Gene Ontology (GO; http://www.geneontology.org)
project is a major collaborative bioinformatics initiative
that aims to standardize the representation of gene and
geneproductattributesacrossspecies.Theprojectprovides
a controlled vocabulary of terms for describing gene prod-
uct characteristics, supports gene product annotation data
from GO Consortium (GOC) members, and develops tools
to access and process these data. Over the past ten years,
the GOC has expanded from its founding three model
organism databases (mouse, yeast and ﬂy) to include the
world’s major repositories for plant, animal and microbial
genomes. GOC makes its ontologies, annotations, and
tools freely available to advance biological research.
ONTOLOGY DEVELOPMENT
The GO continues to mature in representing three aspects
of biology, molecular functions (MF), biological processes
(BP) and cellular components (CC). Table 1 illustrates the
current contents of the GO website and database.
New relationship types and new types of links between terms
Initially, GO used two relationship types to link terms:
is_a and part_of. The original use of the part_of relation-
ship between regulatory processes and the processes that
they regulate did not provide enough speciﬁcity to allow
users to perform queries that distinguish gene products
that play a regulatory role versus a direct role in a biolog-
ical process. In addition, there were no relationships in
the Molecular Function Ontology between regulatory
functions and the functions they regulate. In the past
two years we have added regulates, positively_regulates,
and negatively_regulates relationships between regulatory
terms and their regulated parents. The three regulates
relationships allow GO to correctly represent important
areas of biology where one process aﬀects the manifesta-
tion of another process, molecular function, or quality,
but may not be a part of that process itself. For example
‘regulation of transcription’ is not a part of ‘transcription’,
but lies outside of the transcription process and controls
how it unfolds. The regulates relations in GO are used
speciﬁcally to mean necessarily-regulates, that is: if B
regulates A, then whenever B is present, it always regulates
A, but A may not always be regulated by B. The intro-
duction of these relationships will allow users to ask
important questions about the nature of control processes
that underlie much of biology.
Recently, we have also introduced the has_part relation-
ship to GO. It represents a part–whole relationship
from the perspective of the parent, and is thus the
logical complement to the part_of relationship. In GO,
the relationship A has_part B means that A necessarily
(always) has B as a part; i.e., if A exists then B also
exists as a part of A. If A does not exist, B may or may
not exist. For example, ‘cell envelope’ has_part ‘plasma
membrane’ means that a cell envelope always has a
plasma membrane as a part but a plasma membrane
may exist without being a part of a cell envelope.
Perhaps the most signiﬁcant change is that GO
now contains links between its three diﬀerent branches:
MF, BP, and CC. Speciﬁcally, there are now part_of
relationships between MF and BP and regulates
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MF. (see examples in Figure 1). A thorough discussion of
the various relationship types, both new and old, and their
uses in the GO is available at http://geneontology.org/GO.
ontology-ext.relations.shtml.
The new relationships and new links between ontologies
serve several purposes for the user. First, with links
between ontologies, annotations can now be propagated
from one ontology to another. The most obvious example
of this is the propagation of gene-product annotations
from a MF term to a BP term when the molecular
function has a part_of relationship to a biological
process. It is our hope that our users will go beyond this
very basic beneﬁt of the cross-ontology links and begin to
ask more hypothetical questions using the ontology and
annotations to the ontology. For example, a user could
now ask what gene products might be involved in
regulating a speciﬁc metabolic process if they know a reg-
ulatory process that controls the metabolic process and
they know the types of molecular functions that play
roles in the regulatory process.
New ontology ﬁles
GO is edited and released on a daily basis. Several versions
of GO are available for download (Table 2). An extended
version, in OBO 1.2 format, includes the regulates links,
the has_part links and the intra-ontology part_of links dis-
cussed above and information on when, and by whom, a
term was created. Other versions without this additional
information are made available to accommodate existing
software tools. There are several ways to convert the
OBO-format ﬁle into the Web Ontology Language
(OWL) format (http://www.bioontology.org/wiki/index
.php/OboInOwl:Main_Page). These multiple formats
allow users to use GO in the ways that they always
Figure 1. New intra- and inter-ontology relationships. (A) An example of a regulates link between two BP terms is pointed out by the arrow.
An example of a part_of link between an MF term and a BP term is indicated by the circle. A regulates link between a BP term and an MF term is
indicated by the triangle. (B) An example of a has_part link between two CC terms is pointed out by the arrow.
Table 1. Current status of Gene Ontology as of 4 September 2009
Biological process terms 17069
Molecular function terms 8637
Cellular component terms 2432
Sequence ontology terms 1603
Annotation datasets
a 52
Species with annotation 197439
Annotated gene products
Total 44545253
Electronic
b 43655159
Manual 890094
aMost datasets represent single species; Gramene, the TIGR Gene
Index, UniProt GOA and UniProt PDB represent multiple species.
bAnnotations using the IEA (inferred from electronic annotation)
evidence code.
Table 2. Available GO ontology ﬁles
File name Content Format
gene_ontology_ext.obo extended OBO 1.2
gene_ontology.1_2.obo standard OBO 1.2
gene_ontology.1_0.obo standard OBO 1.0
D332 Nucleic AcidsResearch, 2010, Vol.38,Database issuehave, but also give them the opportunity to take advan-
tage of the most recent extensions that the ontology
has to oﬀer.
New biological content in the ontology
The GOC continues to add terms and modify the ontology
based on annotator and community requests. In addition,
by working with community experts and focusing
on speciﬁc related areas of biology, three areas of GO
have seen signiﬁcant improvements. First, new terms to
describe interactions between organisms have been
added in collaboration with Plant-Associated Microbe
GO (PAMGO) (1). Second, terminology describing the
development of branching organs, focusing on the devel-
opment of the embryonic placenta, prostate gland,
salivary gland, mammary gland and lung (2), has been
elaborated. Third, the GO branch describing all aspects
of heart development has been greatly expanded by the
addition of over 200 terms. One of our goals is to provide
the research community with the richness of terms
required to represent their biology in both breadth and
detail. The GOC encourages those who are interested in
enriching speciﬁc areas of biology in the ontologies to
contact and collaborate with us.
Quality control of the ontology and annotations
Among the beneﬁts of the new links and relationship types
added to the ontology is that they enable partial automa-
tion of ontology-logic quality control. For example, the
reasoner built into OBO-Edit can identify missing is_a
links in the regulation section of the graph based on
existing links in the core biological process graph.
Several additional automated checks are performed and
corrections are made following curatorial review. We have
also begun biological validation of the ontology by
comparing annotations of overlapping sets of genes to
various cellular GO terms that we expect to be mutually
exclusive. Such an analysis reveals potential errors in
either annotation or ontology structure. Finally, a check
has been designed to identify annotations of gene products
from certain species using GO terms that describe pro-
cesses that do not occur in these species (for example,
‘lactation’ for non-mammalian gene products). We plan
to continue to develop both logical and biological
checks of the ontology to ensure both its accuracy and
completeness.
Sequence Ontology
The Sequence Ontology (SO) (http://sequenceontology
.org/) provides the terminology and relations to describe
the key features for genomics and other structural
sequence annotation. The SO is pioneering the OBO
Foundry ontologies in using cross product terms (terms
explicitly deﬁned using two or more other ontology terms)
to manage ontology editing, with over 194 examples. SO
terms are increasingly used in genomic annotation, and
have become the standard terminology for annotation
sharing and dispersal for the model organism community.
There is active development of the ontology and terms and
changes can be suggested to SO using the term tracker.
The SO provides tools to both browse the ontology and
document it using the miSO browser and the SO wiki. The
browser searches either CVS revisions or releases, by term,
synonym or ID, and provides a fully reasoned image of
the term and relations. The SO wiki provides the user with
automated documentation of the status of the term, and
the opportunity for manual ‘community based’ documen-
tation. SO also provides tools to support the update of
legacy sequence to SO compliant formats such as gﬀ3.
Links to all of these resources can be found on the
SO web site.
ANNOTATION OF GENE PRODUCTS
GO Consortium members annotate gene products using
both electronic and manual methods, reﬁning these
methods as new analytical techniques and experimental
methods become available. The resulting annotation sets
are deposited in the GO repository and GO database and
are available for querying using AmiGO. Table 1 shows
the current numbers of datasets, annotated gene products,
and species in which gene products are annotated.
The Reference Genome project (3) jointly annotates
groups of genes across 12 organisms with an emphasis on
coordinated annotation of highly conserved genes and
genes of particular biomedical importance. Inferences
of functions are made using PAINT (Phylogenetic
Annotation INferencing Tool) software, which visualizes
the annotations in a phylogenetic framework [see Mi et al.,
this issue (4)]. Reference genome annotation is an impor-
tant aspect of the GO project in that it takes experimen-
tally derived biological knowledge from a limited number
of model organisms and uses that to infer knowledge
about similar gene products in other organisms within a
phylogenetically basedframework. Thistype ofannotation
and inference extends the ability of GO to be useful in
many diﬀerent biological contexts.
MAKING GO MORE ACCESSIBLE
OBO-Edit improvements
The GO community develops and uses a freely available
Java-based ontology editor, OBO-Edit (5) (http://www
.oboedit.org). OBO-Edit 2.0 was released in April 2009
with many improvements to support ontology editors
working with updated versions of GO. The new version
has completely customizable panel conﬁguration and a
graph-based ontology editor as well as improved searching
abilities with an auto-complete feature. To support cross
products and automated ontology quality control,
OBO-Edit 2.0 has enhanced cross product editing,
extended reasoning capabilities including a new Rule
Based Reasoner, and the ability to assert implied links
and remove redundant ones.
AmiGO improvements
AmiGO (6) (http://amigo.geneontology.org), the GO
web-based browser, has undergone a large number of
improvements with many new features added over
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enrichment tool (used to ﬁnd signiﬁcant shared GO
terms or parents of those GO terms in gene products),
ontology slimming (used to map annotations of gene
products to higher-level terms), community annotation
(in association with the GONuts wiki, http://gowiki
.tamu.edu), and support for the Reference Genome
Project (including special visualizations). AmiGO now
displays the regulates relations and includes electronic
(IEA) annotations.
Many supporting improvements and changes have been
made to AmiGO that improve search quality and the user
interface. An ongoing in-place rewrite of the AmiGO code
allows for major improvements in graphics, speed, ease of
installation, and consistency. Finally, AmiGO now oﬀers
search plugins and widgets for all major platforms and
the ability for users to try upcoming and experimental
software.
Interacting with the user community
GO supports its very active and diverse user community
from an email-based helpdesk (http://www.geneontology
.org/GO.contacts.shtml). The web-based help documenta-
tion has been revised to reﬂect the new relationship types
in the ontology and the new features of the AmiGO
browser. GO now communicates news highlights via a
dedicated web page, RSS feed and Twitter; these
supercede the quarterly newsletter that was emailed to
the GO community in previous years.
SUMMARY
The GO Consortium is responsible for the representation
of gene product knowledge for a large body of biological
data. Over the past several years, we have worked to
improve both the logical framework as well as the
comprehensiveness of the ontologies. We have now put
a system in place that will permit us to continue to
extend the representation of biology in GO. New
relationships will allow more reﬁned queries to be
executed and will begin to allow more hypothesis-
generating questions to be asked using the ontology. The
improvement of the logical structure will allow for
rigorous quality control, ensuring that the ontology
is complete and accurate. These improvements will
aid in using the ontology for classical gene-clustering
experiments by ﬁlling in missing relationships that would
otherwise result in gene products not being clustered.
Ontology improvement along with continued annota-
tion eﬀorts should make GO an ever more complete
representation of the roles that gene products play in a
large array of organisms.
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